Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose

Viatris

Status and phase: Completed; Phase 4

Conditions: Impotence

Treatments: Drug: Viagra (Sildenafil Citrate) 100 mg

Study type: Interventional

Funder types: Industry

Identifiers

NCT00143260

A1481240

Details and patient eligibility

About

Safety/Efficacy of 100mg Viagra at 8 hours post dose in men with mild to moderate erectile dysfunction

Sex: Male

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men 18-70 years of age
• Documented clinical diagnosis of erectile dysfunction of at least 3 months duration.

Exclusion criteria

• Subjects with penile implants
• Subjects with a known history of retinitis pigmentosa.
• Subjects, due to the requirement of 100 mg dosage, who are receiving concomitant treatment with the potent CYP3A4 inhibitor ritonavir.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind